Pfizer's Dividend Yield: A Bold Hunter's Path episode artwork

EPISODE · May 9, 2026 · 1 MIN

Pfizer's Dividend Yield: A Bold Hunter's Path

from The Daily News Now! Business

Pfizers stock has plummeted, but its pharma prowess and potential pipeline payoffs make it a compelling buy. Despite bearish analyst views, the companys track record, recent acquisitions, and new treatments in migraine and oncology offer hope. A steady dividend and a 6.5% yield make it an attractive option for income-seeking investors. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/2c1dfc35a5a6919c

NOW PLAYING

Pfizer's Dividend Yield: A Bold Hunter's Path

0:00 1:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 9, 2026.

What is this episode about?

Pfizers stock has plummeted, but its pharma prowess and potential pipeline payoffs make it a compelling buy. Despite bearish analyst views, the companys track record, recent acquisitions, and new treatments in migraine and oncology offer hope....

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!